VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Feasibility and preclinical efficacy of CD7-unedited CD7 CAR T?cells for T?cell malignancies.
Patterns of care, predictors and outcomes of chemotherapy for uterine carcinosarcoma: a National Cancer Database analysis.
Targeted PI3K/AKT/mTOR therapy for metastatic carcinomas of the cervix: A phase I clinical experience.
What test did I have? Patient uncertainty about prenatal genetic screening.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Targeted PI3K/AKT/mTOR therapy for metastatic carcinomas of the cervix: A phase I clinical experience.
Targeted PI3K/AKT/mTOR therapy for metastatic carcinomas of the cervix: A phase I clinical experience. Oncotarget. 2014 Nov 30; 5(22):11168-79.
View in:
PubMed
subject areas
Adenocarcinoma
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols
Carcinoma, Squamous Cell
Class I Phosphatidylinositol 3-Kinases
Female
Humans
Middle Aged
Molecular Targeted Therapy
Neoplasm Metastasis
Phosphatidylinositol 3-Kinases
Proto-Oncogene Proteins c-akt
PTEN Phosphohydrolase
TOR Serine-Threonine Kinases
Uterine Cervical Neoplasms
authors with profiles
SIQING FU
APOSTOLIA MARIA TSIMBERIDOU
KAREN H LU
DAVID SANGHYUN HONG
ROBERT COLEMAN
AUNG NAING
FILIP JANKU